Literature DB >> 11510336

The Greek version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ).

P Pratsidou-Gertsi1, O Vougiouka, E Tsitsami, N Ruperto, A Siamopoulou-Mavridou, C Dracou, I Daskas, M Trachana, V Alaleou, F Kanakoudi-Tsakalidou.   

Abstract

We report herein the results of the cross-cultural adaptation and validation into the Greek language of the parent's version of 2 health related quality of life instruments. The Childhood Health Assessment Questionnaire (CHAQ) is a disease specific health instrument that measures functional ability in daily living activities in children with juvenile idiopathic arthritis (JIA). The Child Health Questionnaire (CHQ) is a generic health instrument designed to capture the physical and psychosocial well-being of children independently from the underlying disease. The Greek CHAQ CHQ were fully validated with 3 forward and 3 backward translations. A total of 143 subjects were enrolled: 82 patients with JIA (28% systemic onset, 24% polyarticular onset, 10% extended oligoarticular subtype, and 38% persistent oligoarticular subtype) and 61 healthy children. The CHAQ clinically discriminated between healthy subjects and JIA patients, with the systemic, polyarticular and extended oligoarticular subtypes having a higher degree of disability, pain, and a lower overall well-being when compared to their healthy peers. Also the CHQ clinically discriminated between healthy subjects and JIA patients, with the systemic onset, polyarticular onset and extended oligoarticular subtypes having a lower physical and psychosocial well-being when compared to their healthy peers. In conclusion the Greek version of the CHAQ-CHQ is a reliable, and valid tool for the functional, physical and psychosocial assessment of children with JIA.

Entities:  

Mesh:

Year:  2001        PMID: 11510336

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  3 in total

1.  Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment.

Authors:  Panayiota Nalbanti; Florentia Kanakoudi-Tsakalidou; Maria Trachana; Polyxeni Pratsidou-Gertsi; Evangelia Farmaki; Panagiotis Bamidis; Fotios Papachristou
Journal:  Rheumatol Int       Date:  2018-05-29       Impact factor: 2.631

2.  Achievement of clinical remission in patients with juvenile idiopathic arthritis under a 2-10-year Etanercept exposure.

Authors:  Maria Trachana; Polyxeni Pratsidou-Gertsi; Maria Badouraki; Anna Bettina Haidich; Grigoris Pardalos
Journal:  Clin Rheumatol       Date:  2013-04-19       Impact factor: 2.980

3.  The health related quality of life of the employees in the Greek hospitals: assessing how healthy are the health workers.

Authors:  Yannis Tountas; Panayotes T H Demakakos; Yannis Yfantopoulos; Jenny Aga; Lambrini Houliara; Elpida Pavi
Journal:  Health Qual Life Outcomes       Date:  2003-10-27       Impact factor: 3.186

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.